Definium Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference
Get Alerts DFTX Hot Sheet
Join SI Premium – FREE
NEW YORK--(BUSINESS WIRE)-- Definium Therapeutics, Inc. (NASDAQ: DFTX), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced that members of the Company’s management team will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference in New York on Wednesday, June 3, 2026 at 3:10 p.m. EDT.
Audio webcasts and replays of available presentations will be accessible on Definium’s Investor Relations website for up to 90 days following each event.
About Definium Therapeutics
The mission of Definium Therapeutics is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments that unlock healing at scale. Guided by a recognition that patients deserve more than better, Definium is relentlessly advancing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders. By turning evidence into impact, Definium aims to change the trajectory of today’s mental health care crisis and enable a healthier future. Headquartered in New York, Definium Therapeutics trades on Nasdaq under the symbol DFTX.
For more information, visit https://definiumtx.com/ and follow Definium Therapeutics on Instagram, LinkedIn and X.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260521502258/en/
Investor Contact:
Gitanjali Jain
VP, Head of Investor Relations
[email protected]
Media Contact:
[email protected]
Source: Definium Therapeutics, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UAE Opens 15th UN Congress on Crime Prevention and Criminal Justice and Launches Pledge4Justice with First Pledge of Up to USD 5 Million
- Best Crypto to Buy Now: Bitcoin Approaches $90K While Remittix Sets a $0.46 Final Presale Stage
- Dogecoin News Today: A September 24 Transfer Sends 250M DOGE to Binance as Remittix Confirms Its Token Debut
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share